Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

ClinicalTrials.gov ID: NCT05766839

Public ClinicalTrials.gov record NCT05766839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 6:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children Under 12 Years of Age With Hyperkalaemia (EMERALD2)

Study identification

NCT ID: NCT05766839
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Vifor Pharma, Inc.; Industry
Enrollment: 32 participants

Conditions and interventions

Conditions

Hyperkalemia

Interventions

Patiromer Drug

Drug

Eligibility (public fields only)

Age range: 0 Years to 11 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 5, 2025
Primary completion: Nov 30, 2029
Completion: Nov 30, 2030
Last update posted: Mar 12, 2026

2025 – 2030

United States locations

U.S. sites: 13
U.S. states: 10
U.S. cities: 12

Facility	City	State	ZIP	Site status
Children's Hospital Colorado	Aurora	Colorado	80045	Not yet recruiting
UF Health Pediatric Multispecialty Center Site	Jacksonville	Florida	32207	Terminated
Miller School of Medicine, University of Miami	Miami	Florida	33124	Recruiting
Arnold Palmer Hospital for Children	Orlando	Florida	32806	Recruiting
Augusta University - Children's Hospital of Georgia	Augusta	Georgia	30912	Recruiting
University of Illinois College of Medicine	Peoria	Illinois	61605	Recruiting
Boston Children's Hospital	Boston	Massachusetts	02115	Recruiting
Children's Mercy Hospitals and Clinics	Kansas City	Missouri	64108	Recruiting
Duke University Hospital & Medical Center	Durham	North Carolina	27710	Recruiting
Duke University Hospital	Durham	North Carolina	27710	Recruiting
The Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	Recruiting
Vanderbilt Children's Hospital Neurology	Nashville	Tennessee	37232	Recruiting
Texas Tech University Health Sciences Center Amarillo	Amarillo	Texas	79106	Terminated

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05766839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 12, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05766839 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →